MedTrace Logo

Direct Improvement of Quality of Life Using a Tailored Pathway With Quality of Life Diagnosis and Therapy: Randomised Trial in Colorectal Cancer Patients

NCT02321813 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2017-09-25

No results posted yet for this study

Summary

The purpose of the study is to determine whether a quality of life pathway with defined diagnostic and therapeutic options improves quality of life in colorectal cancer patients during follow-up.

Conditions

  • Quality of Life
  • Colorectal Neoplasms

Interventions

BEHAVIORAL

quality of life pathway

Quality of life measurement, diagnosis and tailored therapy (pain therapy, psychotherapy, social support, nutrition, stoma care, physiotherapy, fitness)

OTHER

placebo control

Quality of life measurement

Sponsors & Collaborators

  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV

  • Tumor Center Regensburg

    lead OTHER

Principal Investigators

  • Monika Klinkhammer-Schalke, MD, Ass. Prof. · Tumor Center Regensburg e.V., An-Institute of the University of Regensburg, Germany

  • Michael Koller, Ph.D., Prof. · Center for Clinical Trials, University Regensburg, Germany

  • Wilfried Lorenz, MD, Prof. Ɨ · Tumor Center Regensburg e.V., An-Institute of the University of Regensburg, Germany

  • Ferdinand Hofstädter, MD, Prof. · Johannes Kepler University Linz, Medical Faculty, Austria

  • Jeremy C Wyatt, MD, Prof. · Leeds Institute of Health Sciences, University of Leeds, UK

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2016-11-30
Completion
2017-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02321813 on ClinicalTrials.gov